NCT00002139View on ClinicalTrials.gov

Phase I Study of the Clinical Pharmacology of Azithromycin in Buffy Coat of HIV-Infected Subjects.

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Bacterial InfectionsHIV Infections
Interventions
DRUG

Azithromycin

Trial Locations (1)

67214

Ctr for Phase I Research, Wichita

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00002139 - Phase I Study of the Clinical Pharmacology of Azithromycin in Buffy Coat of HIV-Infected Subjects. | Biotech Hunter | Biotech Hunter